4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0001140361-23-003441
EVP & Chief Financial Officer acquired 63,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schorno Dean L · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-26 | Grant or award : show line 1 in the form | +63,000 | 201,908 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-01-26 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +50,000 | $2.42 | 2032-01-24 | 50,000 | 100,000 | D |
| 2023-01-26 | Grant or award : show line 3 in the form Employee Stock Option (right to buy) | +125,000 | $1.87 | 2033-01-26 | 125,000 | 125,000 | D |
Loading xslF345X03/form4.xml…